Concepedia

Publication | Open Access

A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with Clopidogrel

DOIFull Paper Access

569

Citations

22

References

2004

Year

Adnan Kastrati, Julinda Mehilli, Helmut Schühlen, Josef Dirschinger, Franz Dotzer, Jurriën M. ten Berg, Franz‐Josef Neumann, Hildegard Bollwein, Christian Volmer, Meinrad Gawaz,
New England Journal of Medicine

Abstract

Our data suggest that in patients at low-to-intermediate risk who undergo elective percutaneous coronary intervention after pretreatment with a high loading dose of clopidogrel, abciximab is associated with no clinically measurable benefit within the first 30 days.

References

YearCitations

Page 1